Milestone Pharmaceuticals Inc. - COM (MIST)

Historical Portfolio Holders from Q2 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
28.6M
Holdings value Q3 2024
$43.5M
Value change Q3 2024
-$2.33M
Grand Portfolio weight change Q3 2024
0%
Number of holders
40
Number of buys Q3 2024
11
Number of sells Q3 2024
-10
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 28.6M $43.5M -$2.33M $1.52 40
2024 Q2 30.2M $39.9M -$1.77M $1.32 40
2024 Q1 31.1M $55.6M +$23.9M $1.79 40
2023 Q4 17.8M $29.7M -$3.48M $1.67 38
2023 Q3 19.4M $60M -$3.31M $3.10 37
2023 Q2 20.5M $58.3M -$3.17M $2.85 46
2023 Q1 21.5M $84.7M -$10.2M $3.94 47
2022 Q4 23.7M $93.7M -$29.1M $3.96 55
2022 Q3 20.4M $187M +$10.1M $9.19 44
2022 Q2 20.8M $127M -$2.81M $6.14 30
2022 Q1 21M $135M +$5.03M $6.42 29
2021 Q4 20.2M $133M +$1.82M $6.55 26
2021 Q3 19.9M $114M -$1.09M $5.71 29
2021 Q2 20.1M $111M -$885K $5.50 29
2021 Q1 20.3M $117M -$1.99M $5.79 34
2020 Q4 20.6M $138M +$34M $6.70 33
2020 Q3 15.5M $113M +$42.8M $7.32 28
2020 Q2 9.74M $36.8M +$2.94M $3.78 22
2020 Q1 9.23M $17M -$32.7M $1.84 15
2019 Q4 14.4M $230M +$20.2M $16.01 24
2019 Q3 13.1M $240M -$2.84M $18.65 22
2019 Q2 13.1M $350M +$350M $27.15 24